Associations Between Gastroenteropancreatic Neuroendocrine Neoplasms and Inflammatory Factors: Insights From a Two‐Sample Mendelian Randomization Analysis
Huimin Guo, Yu Li, Bowei Liu, Songtao Liu, Yunhao Li · 2025
Read Associations Between Gastroenteropancreatic Neuroendocrine Neoplasms and Inflammatory Factors: Insights From a Two‐Sample Mendelian Randomization Analysis by Huimin Guo, Yu Li, Bowei Liu, Songtao Liu, Yunhao Li (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12741578.txt.
Description
Huimin Guo and co-authors use nature's randomization to test whether inflammation helps cause rare gut and pancreas tumors. Their 2025 study applies Mendelian randomization, which treats inherited genetic variants as instruments, to ninety-one inflammatory proteins and hundreds of immune cell traits. The outcomes are five subtypes of gastroenteropancreatic neuroendocrine neoplasms.
After correction for multiple testing, three immune signals stood out, all involving a monocyte marker tied to stomach tumors of this family. The strongest more than tripled the odds. Reverse analysis found no sign the tumors drive the inflammation instead. Because genes are fixed at conception, such results resist the reverse-causation traps of ordinary observation. The authors read the monocyte signals as clues to how these tumors arise and where immune-targeted treatment might bite. Rare cancers offer few trial patients, making genetic evidence like this disproportionately valuable.
Catalog record
| CREATOR | Huimin Guo, Yu Li, Bowei Liu, Songtao Liu, Yunhao Li |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |